ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "chondrocytes"

  • Abstract Number: 479 • 2016 ACR/ARHP Annual Meeting

    Type II Collagen Secreted from Articular Chondrocytes Is Mainly Destroyed By Cathepsin S in RA Mice

    Jinjun Zhao1, Qin Huang2, Hao Ren1, Qingqing Ouyang1 and Min Yang1, 1Nanfang Hospital,Southern Medical University, Guangzhou, China, 2Department of Rheumatology, Nanfang Hospital,Southern Medical University, Guangzhou, China

    Background/Purpose: Mast cells have long been recognized to increase strikingly in number in the synovial membrane of rheumatoid arthritis(RA),accounting for 5% of the surface synovial…
  • Abstract Number: 2119 • 2016 ACR/ARHP Annual Meeting

    Wogonin, a Plant-Derived Flavonoid, Exert Anti-Inflammatory and Chondroprotective Effects through the Activation Nrf2/HO-1 Signaling in Human OA Chondrocytes

    Mohammad N. Khan, Abdul Haseeb, Sara Haynie and Tariq M Haqqi, Anatomy & Neurobiology, Northeast Ohio Medical University, Rootstown, OH

    Background/Purpose:   Methods:  Primary human OA chondrocytes were isolated by enzymatic digestion of the cartilage obtained from OA patients who underwent total knee arthroplasty at…
  • Abstract Number: 2123 • 2016 ACR/ARHP Annual Meeting

    Follistatin-like Protein 1 Is a Potent Regulator of Articular Chondrocytes in Osteoarthritis

    Yury Chaly, Bruce Hostager, Sonja Smith and Raphael Hirsch, Stead Family Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, IA

    Background/Purpose: Osteoarthritis (OA) is the most common degenerative disease of the joints, affecting nearly 30 million Americans. It is characterized by a change in chondrocyte…
  • Abstract Number: 2131 • 2016 ACR/ARHP Annual Meeting

    Transient Receptor Potential Ankyrin 1 (TRPA1) Is Functionally Expressed in Primary Human Osteoarthritic Chondrocytes and Mediates Cartilage Destruction and Joint Pain in the Mia-Model of Osteoarthritis

    Elina Nummenmaa1, Lauri J Moilanen1, Mari Hämäläinen1, Erja-Leena Paukkeri1, Riina Nieminen1, Teemu Moilanen2, Katriina Vuolteenaho1 and Eeva Moilanen1, 1The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital, Tampere, Finland, 2Coxa Hospital for Joint Replacement, Tampere, Finland

    Background/Purpose:  Transient receptor potential ankyrin 1 (TRPA1) is a membrane associated cation channel, which is widely expressed in neuronal cells and known to be involved…
  • Abstract Number: 2994 • 2016 ACR/ARHP Annual Meeting

    Binding of Periostin to Discoidin Domain Receptor-1 (DDR1) Promotes Cartilage Degeneration By Inducing MMP-13 Expression

    Yang Qing1, Paolo Mignatti2, Austin Ramme3, Thorsten Kirsch3, Jyoti Patel4 and Mukundan Attur4, 1Medicine, New York University School of Medicine, New York, NY, 2Medicine, New York University, New York, NY, 3Orthopaedic Surgery, New York University, New York, NY, 4Rheumatology Research, NYU - Hospital for Joint Diseases, New York, NY

    Background/Purpose:  We and others have previously shown that periostin (Postn) expression is dramatically elevated in cartilage and sub-chondral bone in OA patients and surgical models…
  • Abstract Number: 1138 • 2015 ACR/ARHP Annual Meeting

    Suppressor of Cytokine Signaling 1 Inhibits Interleukin-1β Induced Matrix Metalloproteinases Expression in Human Chondrocytes By Modulating p38-CREB- C/Ebpβ Pathway

    You Jung Ha1, Yong Seok Choi2, Eun Ha Kang3, Kichul Shin4, Jaehyung Hur1, Yeong Wook Song5 and Yun Jong Lee2, 1Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea, 2Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea, 3Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea, 4Rheumatology, SMG-SNU Boramae Medical Center, Seoul, South Korea, 5Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine Seoul National University, Seoul, South Korea

    Background/Purpose: CAAT/enhancer-binding protein-beta (C/EBPb) is known to be a transcription factor regulating IL-1b-induced catabolic pathways, including the expression of matrix metalloproteinases (MMPs), in chondrocytes. Suppressor…
  • Abstract Number: 1143 • 2015 ACR/ARHP Annual Meeting

    Reduced Hydrogen Sulfide Synthesis in the Joint, a New Player in the Pathogenesis of Osteoarthritis

    Angela Vela-Anero1, Lucia Gato-Calvo2,3, Cristina Ruiz-Romero2,3, Rosa Meijide-Failde1, Francisco J. Blanco3 and Elena F. Burguera3,4, 1Grupo de Terapia Celular y Medicina Regenerativa. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC). Sergas. Universidade de A Coruña (UDC), A Coruña, Spain, 2Grupo de Bioingeniería Tisular y Terapia Celular (GBTTC-CHUAC). CIBER-BBN/ISCIII. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC). Sergas. Universidade de A Coruña (UDC), A Coruña, Spain, 3Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC). Sergas. Universidade de A Coruña (UDC), A Coruña, Spain, 4Grupo de Bioingeniería Tisular y Terapia Celular (GBTTC-CHUAC). CIBER-BBN/ISCIII. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC). Sergas. Universidade de A Coruña (UDC), A Coruna, Spain

    Background/Purpose: Hydrogen sulfide (H2S) is, next to NO and CO, the third endogenous gasotransmitter. It has been shown that in some pathologies, such as hypertension,…
  • Abstract Number: 1147 • 2015 ACR/ARHP Annual Meeting

    TGFß1 Blocks Chondrocyte Hypertrophy and Increases Cell Viability in Cultured Cartilage Explants but Does Not Protect Against Proteoglycan Loss

    Arjan van Caam, Wojciech Madej, Henk van Beuningen, Esmeralda Blaney Davidson and Peter van der Kraan, Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands

    Background/Purpose: In osteoarthritis, cartilage degradation is partly due to chondrocytes gaining a hypertrophy-like phenotype. TGFβ1 is considered to be a protective factor for articular cartilage by blocking…
  • Abstract Number: 2010 • 2015 ACR/ARHP Annual Meeting

    Adenosine A2A Receptor, but Not A2B Receptor, Deletion Leads to Development of Osteoarthritis (OA) in Mice and Administration of a Liposomal Suspension of Adenosine Prevents/Treats Osteoarthritis in Rats

    CARMEN CORCIULO1, MATIN Lendhey2, AUSTIN RAMME2, Tuere Wilder3, ORAN KENNEDY2 and Bruce Cronstein4, 1Medicine, NYU-School of Medicine, New York, NY, 2Department of Orthopaedic Surgery, NYU-School of Medicine, New York, NY, 3Dept of Med, Div of Rheum, NYU School of Medicine, New York, NY, 4Medicine, Division of Rheumatology, NYU School of Medicine, NEW YORK, NY

    Background/Purpose: Adenosine, acting at its receptors, regulates chondrocyte function and inflammation, two components of OA. Mice lacking adenosine A2A receptors (A2AR) have increasing difficulty walking…
  • Abstract Number: 2722 • 2015 ACR/ARHP Annual Meeting

    Cyclic Phosphatidic Acid (CPA) Suppresses Expression of Cartilage Degrading Enzymes Such As MMP-3, MMP-13 and Adamts-4 in Inflammatory Synovial Fibroblasts and Articular Chondrocytes Induced By IL-1 Beta and/or TNF ALFA

    Ikuko Masuda1,2, Kodo Okada3, Hisashi Yamanaka1 and Shigeki Momohara1, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Rheumatology, Jyujyo Takeda Rehabilitation Hospital, Kyoto, Japan, 3SANSHO, Co. Ltd., Tokyo, Japan

    Background/Purpose: Cyclic phosphatidic acid (cPA) is one of bioactive lipid, has been implicated as an mediator of various biological effects including inhibitory effects of proliferation,…
  • Abstract Number: 1128 • 2015 ACR/ARHP Annual Meeting

    Insulin-Induced Cartilage Degradation in Osteoarthritis Is Associated to Defective Autophagy

    Beatriz Carames1, Madalena Ribeiro1,2, Paloma Lopez de Figueroa1, Alexandrina Mendes2 and Francisco J. Blanco1, 1Cartilage Biology Group. Rheumatology Division, INIBIC-Hospital Universitario A Coruña, A Coruña, Spain, 2Centre for Neuroscience and Cell Biology, University of Coimbra; Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal

    Background/Purpose: Autophagy, a key cellular quality control mechanism, is defective in Osteoarthritis (OA) and Type 2 Diabetes (T2D). T2D has been proposed as a risk…
  • Abstract Number: 1131 • 2015 ACR/ARHP Annual Meeting

    A Histone Deacetylase Inhibitor SAHA Induce MCPIP1 Expression and Suppress IL-6 Expression By Upregulating Cebpα Expression and Downregulating the Expression of Mir-9 in Human OA Chondrocytes

    Mohammad Shahidul Makki1 and Tariq Haqqi2, 14209 St Rt 44 PO Box 95, Northeast Ohio Medical University, Rootstown, OH, 2Anatomy & Neurobiology, Northeast Ohio Medical University, Rootstown, OH

    Background/Purpose:   Histone deacetylase inhibitors (HDACi) are a class of compounds that inhibits the histone deacetylase activity. MCPIP1 is a negative regulator of IL-6 expression…
  • Abstract Number: 1026 • 2014 ACR/ARHP Annual Meeting

    Monosodium Urate Monohydrate Crystals Induces the Expression of Ihh and MMP-13 in ATDC5 Cells: Implications in Osteoarthritis (OA) Development.

    Melissa Ramirez1, Josh Potvin1, Diana Ramirez2 and Anthony M. Reginato3, 1Division of Rheumatology, The Warren Alpert School of Medicine at Brown University, Providence, RI, 2Department of Orthopaedic Surgery, The Warren Alpert School of Medicine at Brown University, Providence, RI, 3Rheumatology, The Warren Alpert School of Medicine at Brown University, Providence, RI

    Background/Purpose: Cartilage damage is often observed in affected joints with advance gout1. Musculoskeletal ultrasound studies have highlighted the close relationship between monosodium urate (MSU) crystals…
  • Abstract Number: 1014 • 2014 ACR/ARHP Annual Meeting

    Harpagide, a Low Molecular Weight Natural Product, Suppresses IL-1â-Induced IL-6 Expression By Blocking the Activation of p38 MAPK and Transcription Factors CEBPâ and AP-1 in Primary Human Osteoarthritis Chondrocytes

    Abdul Haseeb1 and Tariq Haqqi2, 1Anatomy and Neurobiology, Northeast Ohio Medical University (NEOMED), Rootstown, OH, 2Anatomy & Neurobiology, Northeast Ohio Medical University, Rootstown, OH

    Background/Purpose: There is growing evidence that shows the involvement of IL-6 in cartilage degradation during OA. Significant correlation between IL-6 levels in serum as well…
  • Abstract Number: 1012 • 2014 ACR/ARHP Annual Meeting

    Role of High Glucose Environment on Chondrocyte Activation and Characterization of Diabetic Osteoarthritic Cartilage: Toward Pathophysiological Delineation of Diabetes Mellitus-Related Osteoarthritis

    Marie-Charlotte Laiguillon1, Alice Courties1,2, Xavier Houard1, Martine Auclair1, Alain Sautet3, Bruno Fève1, Jacqueline Capeau1, Francis Berenbaum2 and Jérémie Sellam2, 1Sorbonne Universités, UPMC Univ Paris 06, UMRS 938 and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Paris, France, 2AP-HP, Saint-Antoine Hospital, Rheumatology Department and DHU i2B, Paris, France, 3AP-HP, Saint-Antoine Hospital, Orthopaedic Surgery Department, Paris, France

    Background/Purpose: Recent epidemiological studies have suggested an association between type 2 diabetes/hyperglycemia and osteoarthritis (OA) but experimental evidences are lacking (1). We aimed i) to…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology